6.70
6.70 (0%)
As of Feb 14, 2025
Meiragtx Holdings Plc [MGTX]
Source:
Company Overview
Meiragtx Holdings Plc is a vertically integrated, clinical-stage genetic medicines company with a broad pipeline of late-stage clinical programs, including Parkinson’s disease, radiation-induced xerostomia and AIPL1-associated retinal dystrophy.
| Country | United States |
| Headquarters | new york, new york |
| Phone Number | ( 646 ) 860-7985 |
| Industry | manufacturing |
| CEO | Alexandria Forbes, Ph.D. |
| Website | www.clinicaltrials.gov |